QS Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$13.6M Buy
67,659
+11,126
+20% +$2.24M 0.16% 95
2021
Q1
$12.1M Buy
56,533
+9,734
+21% +$2.09M 0.14% 112
2020
Q4
$11.1M Buy
46,799
+3,790
+9% +$896K 0.13% 124
2020
Q3
$11.7M Buy
43,009
+4,551
+12% +$1.24M 0.16% 112
2020
Q2
$11.2M Sell
38,458
-406
-1% -$118K 0.16% 115
2020
Q1
$9.25M Buy
38,864
+500
+1% +$119K 0.15% 122
2019
Q4
$8.42M Buy
38,364
+3,315
+9% +$727K 0.08% 180
2019
Q3
$5.94M Buy
35,049
+15,368
+78% +$2.6M 0.06% 237
2019
Q2
$3.61M Buy
19,681
+300
+2% +$55K 0.04% 373
2019
Q1
$3.57M Sell
19,381
-126
-0.6% -$23.2K 0.04% 375
2018
Q4
$3.23M Sell
19,507
-6,365
-25% -$1.05M 0.04% 355
2018
Q3
$4.99M Sell
25,872
-1,940
-7% -$374K 0.05% 280
2018
Q2
$4.73M Buy
27,812
+2,010
+8% +$342K 0.05% 306
2018
Q1
$4.21M Hold
25,802
0.04% 315
2017
Q4
$3.87M Buy
25,802
+5,703
+28% +$855K 0.04% 381
2017
Q3
$3.06M Buy
20,099
+7,904
+65% +$1.2M 0.02% 466
2017
Q2
$1.57M Sell
12,195
-2,400
-16% -$309K 0.01% 651
2017
Q1
$1.6M Buy
14,595
+8,061
+123% +$881K 0.01% 664
2016
Q4
$481K Hold
6,534
﹤0.01% 895
2016
Q3
$570K Sell
6,534
-252
-4% -$22K ﹤0.01% 864
2016
Q2
$584K Sell
6,786
-612
-8% -$52.7K 0.01% 877
2016
Q1
$588K Buy
7,398
+1,108
+18% +$88.1K 0.01% 874
2015
Q4
$791K Buy
6,290
+24
+0.4% +$3.02K 0.01% 830
2015
Q3
$653K Sell
6,266
-1,760
-22% -$183K 0.01% 845
2015
Q2
$991K Buy
8,026
+1,800
+29% +$222K 0.01% 761
2015
Q1
$734K Hold
6,226
0.01% 804
2014
Q4
$740K Sell
6,226
-1,000
-14% -$119K 0.01% 790
2014
Q3
$812K Sell
7,226
-500
-6% -$56.2K 0.02% 389
2014
Q2
$731K Buy
7,726
+2,151
+39% +$204K 0.02% 425
2014
Q1
$394K Sell
5,575
-1,100
-16% -$77.7K 0.01% 485
2013
Q4
$496K Sell
6,675
-600
-8% -$44.6K 0.02% 429
2013
Q3
$551K Sell
7,275
-825
-10% -$62.5K 0.02% 411
2013
Q2
$654K Buy
+8,100
New +$654K 0.02% 469